Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Lawrence W. Hamilton
AddedFeb 19, 2024
UpdatedMay 31, 2026
Lawrence W. Hamilton

Lawrence W. Hamilton

Board Member, Treace Medical Concepts

LinkedInThe Org

Lawrence W. Hamilton's Career

Treace Medical Concepts
Treace Medical Concepts

Ponte Vedra, FL, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Lawrence W. Hamilton's Career

Treace Medical Concepts
Treace Medical Concepts
Public$212.9M1682014Ponte Vedra, FL, US
Board Member· Board

Leadership at Treace Medical Concepts

James T. TreaceJames T. TreaceBoard Member
Mr. John T. TreaceMr. John T. TreaceFounder
Lance A. BerryLance A. BerryBoard Member
John K. BakewellJohn K. BakewellBoard Member
Rich MottRich MottBoard Member

Similar to Treace Medical Concepts

Trice MedicalTrice MedicalMalvern, PA, USMedical Devicesest. 2012Trice MedicalMalvern, PA, US · est. 2012

Trice Medical: Providing micro-invasive orthopedic diagnostic devices and patient care solutions in Pennsylvania.

Series A · $106.2M52
Trice OrthopedicsTrice OrthopedicsKing of Prussia, PA, USMedical Devicesest. 2012Trice OrthopedicsKing of Prussia, PA, US · est. 2012

Trice: Revolutionizing orthopedic diagnostics with instant, accurate office-based solutions.

Seed · $3M11
Fusion OrthopedicsFusion OrthopedicsMesa, AZ, USMedical Devices, Surgeryest. 2014Fusion OrthopedicsMesa, AZ, US · est. 2014

Fusion Orthopedics LLC: Specialized in general medicine and surgery since 2016.

Seed · $355k19
Concept MedicalConcept MedicalTampa, FL, USMedical Devicesest. 2008Concept MedicalTampa, FL, US · est. 2008

Concept Medical: Innovating treatments for coronary and peripheral artery diseases with advanced medical devices.

Series D · $60M234

Lawrence W. Hamilton's Similar Executives & Operators

Lau Eng BoonLau Eng BoonBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailHiroshi MikitaniHiroshi MikitaniBoard Member · RakutenKen KutaragiKen KutaragiBoard Member · RakutenTakashi MitachiTakashi MitachiBoard Member · Rakuten

People Similar to Lawrence W. Hamilton

Dan PosilovichDan PosilovichBoard Member · TransceptaHelen RyanHelen RyanBoard Member · Enterprise IrelandRobert K. KameiRobert K. KameiBoard Member · ZedaIan JulianoIan JulianoBoard Member · Trella Health